|
Market Closed -
Bombay S.E.
03:32:26 30/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 136.45 INR | -0.15% |
|
+7.78% | +89.80% |
| 16/10 | Zim Laboratories Limited Receives Tga Gmp Certification for Its Manufacturing Facility | CI |
| 18/09 | ZIM Laboratories Limited Incorporates Wholly Owned Subsidiary In Chile | CI |
| Market Cap | 732.17Cr 7.71Cr 6.91Cr 6.35Cr 5.76Cr 11Cr 11Cr 76Cr 30Cr 385.14Cr 29Cr 28Cr 1.21TCr | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 818.48Cr 8.62Cr 7.72Cr 7.1Cr 6.43Cr 12Cr 12Cr 85Cr 34Cr 430.54Cr 32Cr 32Cr 1.36TCr | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.77% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| ZIMLAB | Delayed | |
NSE India S.E.
| ZIMLAB | End-of-day quote |
Last Transcript: ZIM Laboratories Limited
| 1 day | -0.15% | ||
| 1 week | +7.78% | ||
| 1 month | -1.09% | ||
| 3 months | +19.90% | ||
| 6 months | +55.02% | ||
| Current year | +89.80% |
| 1 week | 121.05 |  | 143.55 |
| 1 month | 121.05 | | 160.1 |
| Current year | 59.72 | | 160.1 |
| 1 year | 59.72 | | 160.1 |
| 3 years | 59.72 | | 160.1 |
| 5 years | 36.37 | | 160.1 |
| 10 years | 14 | | 160.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 01/01/2002 |
| Director of Finance/CFO | - | 01/04/2019 | |
| Director of Finance/CFO | - | 01/01/1991 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 01/01/1990 |
| Director/Board Member | - | 01/01/1991 | |
Prakash Sapkal
BRD | Director/Board Member | - | 01/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | +7.78% | +85.75% | +16.77% | 7.71Cr | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,26300Cr | |
| -0.73% | +3.56% | +44.65% | +84.17% | 66TCr | |
| +1.41% | +3.24% | +35.25% | +108.88% | 52TCr | |
| +0.42% | +3.20% | +55.81% | +72.50% | 39TCr | |
| +2.18% | +2.93% | +73.90% | +45.59% | 37TCr | |
| +1.12% | +4.52% | +34.76% | +58.24% | 31TCr | |
| +6.96% | +8.86% | +11.95% | +36.20% | 29TCr | |
| +1.15% | +6.09% | +56.15% | +82.25% | 25TCr | |
| +3.06% | +9.38% | +42.48% | +117.32% | 21TCr | |
| Average | +1.86% | +6.09% | +50.50% | +77.78% | 42.62TCr | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.51% | +100.43% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 379.13Cr 3.99Cr 3.58Cr 3.29Cr 2.98Cr 5.57Cr 5.68Cr 39Cr 16Cr 199.44Cr 15Cr 15Cr 628.95Cr | 374.4Cr 3.94Cr 3.53Cr 3.25Cr 2.94Cr 5.5Cr 5.6Cr 39Cr 16Cr 196.95Cr 15Cr 14Cr 621.09Cr |
| Net income | 12Cr 12.81L 11.47L 10.55L 10L 17.88L 18.21L 1.26Cr 50.53L 6.4Cr 48.08L 47.06L 20Cr | 5.84Cr 6L 6L 5L 5L 9L 9L 60.4L 24.25L 3.07Cr 23.07L 22.58L 9.68Cr |
| Net Debt | 115.76Cr 1.22Cr 1.09Cr 1Cr 91.01L 1.7Cr 1.73Cr 12Cr 4.81Cr 61Cr 4.58Cr 4.48Cr 192.04Cr | 86Cr 90.9L 81.41L 74.88L 67.85L 1.27Cr 1.29Cr 8.93Cr 3.58Cr 45Cr 3.41Cr 3.34Cr 143.18Cr |
Employees
632
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | ₹136.45 | -0.15% | 4,839 |
| 29/26/29 | ₹136.65 | -3.63% | 4,488 |
| 28/26/28 | ₹141.80 | +6.30% | 11,197 |
| 27/26/27 | ₹133.40 | +4.92% | 6,926 |
| 26/26/26 | ₹127.15 | +0.43% | 9,087 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
